10 March 2025: The UK Government has accepted the majority of recommendations from the Regulatory Horizons Council (RHC) regarding the regulation of artificial intelligence (AI) in medical devices, aiming to balance patient safety with innovation. Government Endorsement of AI in MedTech Regulations The Department for Health and Social Care (DHSC)
Denham, 7 March 2025 – ITK Engineering, a global technology firm and subsidiary of Robert Bosch, is expanding into the UK MedTech sector. With 30 years of expertise in software and systems engineering, the EN ISO 13485-certified company will support medical innovators in one of the world’s most dynamic healthcare
19 March 2025, Ras Al Khaimah: Ras Al Khaimah’s real estate sector is entering a dynamic phase of rapid expansion, driven by increasing demand, rising property values, and significant economic developments. Industry experts predict sustained growth, making RAK an attractive destination for investors, homeowners, and businesses alike. According to
Basel, 12 March 2025 – Roche has entered into an exclusive collaboration and licensing agreement with Zealand Pharma (a Danish biotechnology research company) to co-develop and co-commercialise Zealand Pharma’s amylin analog, petrelintide. The partnership covers both standalone use and a fixed-dose combination with Roche’s lead incretin asset, CT-388. Under
Geneva, February 17, 2025: Unilabs, a top diagnostic services provider in Europe, has partnered with Oxipit, a leading medical imaging AI company, to implement AI-powered chest X-ray solutions across its European network. Through this partnership, Unilabs will integrate Oxipit’s AI solutions, ChestLink and ChestEye, into its radiology workflows, enhancing